69 related articles for article (PubMed ID: 2737581)
1. [Injection aids for intermediate-term acting insulin. Experiences with the OptiPen].
Schifferdecker E; Jungmann E; Schöffling K
Fortschr Med; 1989 May; 107(15):348-50. PubMed ID: 2737581
[TBL] [Abstract][Full Text] [Related]
2. [Feasibility and acceptability of insulin therapy using a pen suitable for injecting regular or intermediate insulin. Results of the French multicenter study conducted by the Optipen-France Study Group].
Pinget M; Vexiau P; Sandre D; Pasqual C; Weisselberg C
Diabete Metab; 1990 Dec; 16(6):492-7. PubMed ID: 2086280
[TBL] [Abstract][Full Text] [Related]
3. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patient preferences.
Fisken RA; Goulbourn J
Diabetes Res; 1989 Aug; 11(4):195-7. PubMed ID: 2696619
[TBL] [Abstract][Full Text] [Related]
4. [Control of diabetes mellitus with the insulin pen. Adequately managed?].
van der Loos TL
Ned Tijdschr Geneeskd; 1989 Jun; 133(23):1183-4. PubMed ID: 2664533
[TBL] [Abstract][Full Text] [Related]
5. [Long-term therapy with human insulin. Clinical experiences].
Sachse G; Mäser E; Federlin K
Dtsch Med Wochenschr; 1985 Mar; 110(11):403-6. PubMed ID: 3884307
[TBL] [Abstract][Full Text] [Related]
6. [Insulin injection aid. Experiences with its use in Type II diabetes patients].
Piniek W; Kurth E; Bartels O
Fortschr Med; 1991 Oct; 109(31):627-30. PubMed ID: 1743606
[TBL] [Abstract][Full Text] [Related]
7. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
[TBL] [Abstract][Full Text] [Related]
8. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
[TBL] [Abstract][Full Text] [Related]
9. [Insuject-X for children. A clinical trial of the NPH insulin pen].
Rix M; Voght H; Nielsen K; Jakobsen G; Holsteen V
Ugeskr Laeger; 1990 Apr; 152(15):1086-9. PubMed ID: 2184557
[TBL] [Abstract][Full Text] [Related]
10. [Semiautomatic insulin injection equipment (pens)].
Ganz K; Theintz G; Gerber P; Assal JP
Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1228-9. PubMed ID: 2237052
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of diabetes and quality of life. On possibilities of a more normalized life style using an insulin pen for multi-injection therapy].
Andresen IL; Haug J; Jervell J; Paus PN
Tidsskr Nor Laegeforen; 1989 Feb; 109(6):677-80. PubMed ID: 2646754
[TBL] [Abstract][Full Text] [Related]
12. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
Clarke A; Spollett G
Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
[TBL] [Abstract][Full Text] [Related]
13. Functionality and acceptability of a new electronic insulin injection pen with a memory feature.
Venekamp WJ; Kerr L; Dowsett SA; Johnson PA; Wimberley D; McKenzie C; Malone J; Milicevic Z
Curr Med Res Opin; 2006 Feb; 22(2):315-25. PubMed ID: 16466603
[TBL] [Abstract][Full Text] [Related]
14. [Insulin therapy].
Brunetti P
Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
[TBL] [Abstract][Full Text] [Related]
15. [Intensified insulin therapy. References for general practice for increased control].
Dreyer M
MMW Fortschr Med; 2000 May; 142(21):42-4, 46, 48 passim. PubMed ID: 10872294
[TBL] [Abstract][Full Text] [Related]
16. [Fear of long-term injections. Insulin therapy--soon treatment also without injection].
MMW Fortschr Med; 2002 Jun; 144(23):8. PubMed ID: 12119913
[No Abstract] [Full Text] [Related]
17. Possible problem with Optipen Pro-1: should diabetic patients continue to use this product?
Goksen D; Darcan S; Buyukinan M; Kurt E
Diabetes Care; 2006 Jul; 29(7):1710-1. PubMed ID: 16801608
[No Abstract] [Full Text] [Related]
18. Insulin glargine (Lantus).
Owens DR; Griffiths S
Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
[TBL] [Abstract][Full Text] [Related]
19. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.
Small M; MacRury S; Boal A; Paterson KR; MacCuish AC
Diabetes Res; 1988 Jun; 8(2):85-9. PubMed ID: 3067951
[TBL] [Abstract][Full Text] [Related]
20. [The risk of diabetes mellitus in relatives of diabetics treated with insulin].
Barros H; Pignatelli D; Pereira S; Oliveira JP; Maia JC
Acta Med Port; 1994 Jun; 7(6):349-52. PubMed ID: 7942136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
